Manulife Singapore Partners with Guardant Health to Provide Cancer Treatments

MT Newswires Live

2024/12/11

Manulife Singapore has partnered with oncology treatment company Guardant to provide its customers access to the Guardant360 liquid biopsy test, according to a company release on Tuesday.

The company has also teamed up with AMILI which provides advanced gut microbiome screening.

The Guardant360 test carries out genomic profiling of advanced solid cancers and identifies biomarkers through blood samples.

Patients can see their results within seven days.

Through the partnership with AMILI, Manulife will be able provide its customers with personalized insights to improve their immunity, nutrition and brain health.

免责声明：投资有风险，本文并非投资建议，以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请，作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考，不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证，投资者应自行研究并在投资前寻求专业建议。

热议股票

{"basename":"/hans","ssrTDKData":{"titleTemplate":"%s - 老虎证券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎证券,老虎证券开户,老虎券商,老虎证券官网,老虎证券app,tigertrade老虎证券,股票,炒股,新加坡股票交易平台,投资,投资理财","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/hans/news/2490001917"},"companyName":"老虎证券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"2490001917\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/2490001917?lang=zh_CN&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2024-12-11 11:58","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2490001917","market":"fut","top_or_hot":-1,"title":"Manulife Singapore Partners with Guardant Health to Provide Cancer Treatments","media":"MT Newswires Live","content":"<html><body><p> Manulife Singapore has partnered with oncology treatment company Guardant to provide its customers access to the Guardant360 liquid biopsy test, according to a company release on Tuesday.</p><p>The company has also teamed up with AMILI which provides advanced gut microbiome screening.</p><p>The Guardant360 test carries out genomic profiling of advanced solid cancers and identifies biomarkers through blood samples.</p><p>Patients can see their results within seven days.</p><p>Through the partnership with AMILI, Manulife will be able provide its customers with personalized insights to improve their immunity, nutrition and brain health.</p></body></html>","source":"mtnewswires_news","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Manulife Singapore Partners with Guardant Health to Provide Cancer Treatments</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nManulife Singapore Partners with Guardant Health to Provide Cancer Treatments\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1092851196\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/3002d84abbd5ace3c99397c7f95b8d4e);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">MT Newswires Live </p>\n<p class=\"h-time\">2024-12-11 11:58</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<html><body><p> Manulife Singapore has partnered with oncology treatment company Guardant to provide its customers access to the Guardant360 liquid biopsy test, according to a company release on Tuesday.</p><p>The company has also teamed up with AMILI which provides advanced gut microbiome screening.</p><p>The Guardant360 test carries out genomic profiling of advanced solid cancers and identifies biomarkers through blood samples.</p><p>Patients can see their results within seven days.</p><p>Through the partnership with AMILI, Manulife will be able provide its customers with personalized insights to improve their immunity, nutrition and brain health.</p></body></html>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"BK4588","symbol_name":"碎股","start_time":0,"source_url":"https://www.mtnewswires.com/","article_id":"2490001917","we_media_id":"1092851196","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2490001917","pubTimestamp":1733889503,"columns":[],"sourceInfo":{"source_id":"mtnewswires_news","name":"MT Newswires"},"weMediaInfo":{"media_name":"MT Newswires Live","introduction":"The most recognized names in North America, Europe and Asia rely on MT Newswires to power their applications. Better news, better service, better price.","home_visible":1,"id":"1092851196","head_image":"https://community-static.tradeup.com/news/3002d84abbd5ace3c99397c7f95b8d4e"},"summary":"Manulife Singapore has partnered with oncology treatment company Guardant to provide its customers access to the Guardant360 liquid biopsy test, according to a company release on Tuesday.The company has also teamed up with AMILI which provides advanced gut microbiome screening.The Guardant360 test carries out genomic profiling of advanced solid cancers and identifies biomarkers through blood samples.Patients can see their results within seven days.Through the partnership with AMILI, Manulife will be able provide its customers with personalized insights to improve their immunity, nutrition and brain health.","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"BK4588":"碎股","BK4162":"人寿与健康保险","MFC":"宏利金融","BK4585":"ETF&股票定投概念"},"translate_title":"宏利新加坡与Guardant Health合作提供癌症治疗","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"MFC":1},"content_text":"Manulife Singapore has partnered with oncology treatment company Guardant to provide its customers access to the Guardant360 liquid biopsy test, according to a company release on Tuesday.The company has also teamed up with AMILI which provides advanced gut microbiome screening.The Guardant360 test carries out genomic profiling of advanced solid cancers and identifies biomarkers through blood samples.Patients can see their results within seven days.Through the partnership with AMILI, Manulife will be able provide its customers with personalized insights to improve their immunity, nutrition and brain health.","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"0","news_tag":"","news_rank":0,"symbols":[],"gpt_button":1,"need_auth":false,"code":"91000000","status":"200"}}}